Chimeric Therapeutics
  1. Companies
  2. Chimeric Therapeutics
  3. Products
  4. Chimeric - Model CHM 1301 (CLTX CAR NK) ...

ChimericModel CHM 1301 (CLTX CAR NK) - NK Cell Derived Allogeneic Therapies

SHARE

CHM 1301 (CLTX CAR NK) will be developed on the next generation CORE-NK platform leveraging our CLTX Chimeric Antigen Receptor.